Year: 2020

Oxford Biomedica Appoints Dr. Sam Rasty as Non-Executive Director         Oxford, UK – 23 November, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, is pleased to announce that, with effect from 1 December 2020, Dr. Siyamak (“Sam”) Rasty has been appointed to the Group’s Board as a Non-Executive Director.Dr. Rasty brings more than 20 years of leadership experience in biopharma R&D, commercial, business development, strategy and operations at global large and medium-sized pharmaceutical and early stage, private biotechnology companies. He is currently the President and Chief Executive Officer of PlateletBio, a US-based pioneering cell-based therapeutics company. Previously, he served as Chief Operating Officer at Homology Medicines, Inc., a genetic medicines company that...

Oxford Biomedica notes AstraZeneca’s AZD1222 met primary efficacy endpoint in preventing COVID-19         Oxford, UK – 23 November, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, notes AstraZeneca PLC (“AstraZeneca”) announced AZD1222 met primary efficacy endpoint in preventing COVID-19.Key highlights from the announcement were as follows:Two different dosing regimens demonstrated efficacy with one showing a better profileNo hospitalisations or severe cases of COVID-19 in participants treated with AZD1222One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose followed by a full dose at least one month apart, and another dosing regimen (n=8,895) showed 62% efficacy when given two full doses at least one month apartNo serious safety...

HOUSTON, Nov. 23, 2020 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) is pleased to announce the addition of Firm Body Pilates Training as a new tenant to its Citadel property in North Scottsdale, Arizona.“Every moment of our life can be the beginning of great things.” — Joseph Pilates. “As the country embraces the re-opening of gyms and fitness centers in select areas across the nation, we are pleased to partner with such an experienced and well-respected fitness instructor and entrepreneur,” said Jim Mastandrea, Chairman and CEO of Whitestone REIT. “Pilates has been one of the few segments of the fitness industry that has shown resiliency despite the government-mandated shutdowns during the pandemic and has thrived due to its smaller class sizes and location flexibility. At Whitestone, we have always encouraged and supported the entrepreneurial spirit...

CRANBURY, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference being held virtually on Tuesday, December 1, 2020 at 2:15 p.m. E.T.A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.About Amicus TherapeuticsAmicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline...

Summit Therapeutics Inc.(‘Summit,’ the ‘Company,’ or the ‘Group’)Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating OfficerCambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective immediately.  Dr. Zanganeh is currently a member of the Company’s Board of Directors, having been appointed on November 11, 2020. “Maky’s strategic leadership and operational expertise provide immeasurable value to Summit, as she joins us during this critical time within our ongoing Phase 3 clinical trials of our precision antibiotic candidate, ridinilazole, where we seek to bring a superior treatment to patients with C. difficile infection,” said Bob Duggan, Executive Chairman and Chief Executive Officer of...

MADISON, Wis., Nov. 23, 2020 (GLOBE NEWSWIRE) — The school year looks markedly different this time around for Louisiana Tech University, but campus leaders are confident they have the perfect mix of synchronous and asynchronous learning tools to provide the same quality education  their students expect. Instructors are using Mediasite lecture videos and real-time Zoom calls to continue teaching and learning and improve student outcomes.  “Tools like Mediasite improve access to education for our students,” said Thomas Hoover, CIO, Louisiana Tech University. “We scaled up Mediasite campus-wide within one week in the spring. It will continue to be a great retention tool for students because we can create equity in the classroom and better outcomes for those who have difficulty working in a traditional class environment.”  This fall,...

LOS ANGELES, Nov. 23, 2020 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (CSE:VS) (OTCQB:VRSSF) (FRANKFURT:BMVA), today announced that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed public offering of its common shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined.Versus has also applied to list its common shares on The Nasdaq Capital Market under the ticker symbol “VS.” The Company believes it meets the initial listing requirements for The Nasdaq Capital Market except for the equity standard requirement, which the Company anticipates satisfying upon closing of this proposed public offering.Lake Street Capital Markets, LLC is acting as representative of...

BASEL, Switzerland, Nov. 23, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences:Evercore ISI 3rdAnnual HealthCONx Virtual Conference on December 1, 2020 at 4:45 p.m. Eastern time. Lynn Seely, M.D., chief executive officer of Myovant Sciences, Inc., and Frank Karbe, president and chief financial officer of Myovant Sciences, Inc., will participate in a webcast presentation. Management will also participate in virtual one-on-one investor meetings on December 1.Piper Sandler 32ndAnnual Virtual Healthcare Conference. A pre-recorded presentation by Dr. Seely will be available at 10 a.m. Eastern time today on the investor relations page of Myovant’s website, investors.myovant.com....

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Kerr Mines Inc. (TSX: KER, OTC: KERMF) (“Kerr” or the “Company”) and Star Royalties Ltd. (“Star Royalties”) are very pleased to jointly announce the closing of the first installment of their previously announced US$18,000,000 gold purchase and sale agreement (“Streaming Agreement”) which will be used to finance the restart of underground operations and gold production at the Copperstone Gold Mine (“Copperstone”) in Arizona, USA.Giulio T. Bonifacio, Chief Executive Officer of Kerr, stated: “We are excited to enter this new chapter for Kerr Mines with the closing of this first installment of the Copperstone stream financing. We look forward to working with Star Royalties to expeditiously restart operations at our flagship asset. Our focus now shifts to securing long term lead items, finalizing...